AI Article Synopsis

  • The Clinical and Translational Science Award (CTSA) Program consists of nearly 60 academic medical centers in the U.S., aimed at promoting the diffusion of translational research innovations.
  • The Accrual to Clinical Trials (ACT) Network launched in January 2018, utilizing mixed-methods to track how well the initiative spread and was adopted among the CTSAs until July 2019.
  • Findings showed that by mid-2019, almost 80% of CTSAs participated in the ACT Network, and the process highlighted important lessons about effective dissemination strategies, including the need for two-stage adoption, local user feedback, and ongoing engagement to improve uptake and implementation.

Article Abstract

Introduction: The Clinical and Translational Science Award (CTSA) Program is a Consortium of nearly 60 academic medical research centers across the USA and a natural network for evaluating the spread and uptake of translational research innovation across the Consortium.

Methods: Dissemination of the Accrual to Clinical Trials (ACT) Network, a federated clinical informatics data network for population-based cohort discovery, began January 2018 across the Consortium. Diffusion of innovation theory guided dissemination design and evaluation. Mixed-methods assessed the spread and uptake across the Consortium through July 1, 2019 (n = 48 CTSAs). Methods included prospective time activity tracking (Kaplan-Meier curves), and survey and qualitative interviews.

Results: Within 18 months, nearly 80% of CTSAs had joined the data network and two-thirds of CTSAs achieving technical readiness had initiated launch to local clinical investigators. Over 10,000 ACT Network queries are projected for 2019; and by 2020, nearly all CTSAs will have joined the network. Median time-from-technical-readiness-to-local-launch was 154 days (interquartile range: 87-225 days]. Quality improvement processes reduced time-to-launch by 35.2% (64 days, p = 0.0036). Lessons learned include: (1) conceptualize dissemination as two-stage adoption demonstrating value for both CTSA hub service providers and clinical investigators; (2) include institutional trial into dissemination strategies so CTSA hubs can refine internal workflows and gather local user feedback endorsement; (3) embrace designing-for-dissemination during technology development; and (4) sustain adaptive dissemination and customer relationship management to keep CTSA hubs and users engaged.

Conclusions: Scale-up and spread of the ACT Network provides lessons learned for others disseminating innovation across the CTSA Consortium. The Network is primed for embedded implementation research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057421PMC
http://dx.doi.org/10.1017/cts.2020.505DOI Listing

Publication Analysis

Top Keywords

network
9
accrual clinical
8
clinical trials
8
trials network
8
clinical translational
8
translational science
8
science award
8
spread uptake
8
data network
8
clinical investigators
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!